2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone
First Claim
Patent Images
1. A method of treating a subject suffering from a biological disorder selected from the group consisting of asthma and eczema, comprising administering an effective amount of a compound of formula 1A1 or 1B1, a mixture thereof, or a pharmaceutical formulation comprising the compound or mixture of compounds and a pharmaceutically acceptable carrier to the subject,
0 Assignments
0 Petitions
Accused Products
Abstract
Compounds of formula 1A and 1B are provided where X1 and X2 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological disorders.
-
Citations
14 Claims
- 1. A method of treating a subject suffering from a biological disorder selected from the group consisting of asthma and eczema, comprising administering an effective amount of a compound of formula 1A1 or 1B1, a mixture thereof, or a pharmaceutical formulation comprising the compound or mixture of compounds and a pharmaceutically acceptable carrier to the subject,
- 10. A method of treating hypercalcemia, sarcoidosis, or vitamin D intoxication in an animal subject suffering from hypercalcemia, sarcoidosis, or vitamin D intoxication, comprising administering a compound of formula 1A1 or 1B1, a mixture thereof, or a pharmaceutical formulation comprising the compound or mixture of compounds and a pharmaceutically acceptable carrier to the animal subject,
Specification